Immunotherapy combination could be alternative to 'Extreme' chemotherapy in some head and neck cancers
An immunotherapy combination could be better than standard "Extreme" chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III trial suggests.
Oct 12, 2021
0
12